VERIFIEDMint Companies·24 Aug 2026neutral

After the lottery win: why Dr Reddy’s may be doing much more in its laboratories

AI Summary

·Dr Reddy's reported record profits driven by a copycat drug.
·The company's co-chairman, G.V. Prasad, faces the challenge of sustaining growth without this drug.
·Future growth may depend on biosimilars and innovation within the company's laboratories.